By Reuters April 25, 201812:19 PM UTCUpdated ago April 25 (Reuters) - Cadila Healthcare Ltd: * SAYS ZYDUS GETS FINAL APPROVAL FROM USFDA FOR METHYLPREDNISOLONE TABLETS USP AND CINACALCET ...

An unadjusted analysis of the primary end point showed an odds ratio for a worse outcome of 0.82 (95% CI, 0.67 to 1.00) and a win ratio of 1.15 (95% CI, 1.00 to 1.32) in the methylprednisolone ...